Pharma News

BREAKING! 33 Common Drugs May Be Secretly Causing Kidney Stones in Thousands of People!

Nikhil Prasad Mar 31, 2025 20 days ago

Thailand Pharma News: A startling new study by Chinese researchers has uncovered that 33 widely used medications could be silently increasing the risk of kidney stones - without any warning listed on their official drug labels. The research, conducted by Pan Ding, Qinghua Luo, and Leihua Cao from the Department of Urology at Nanchang People’s Hospital, dives deep into millions of adverse dru...

EU Countries to Stop Buying Antibiotics and Other Drugs from India, China, Japan, and South-East Asian Countries

Nikhil Prasad Mar 12, 2025 1 month ago

Thailand Pharma News: EU Aims to Cut Reliance on Asian Drug Suppliers The European Union (EU) has announced plans to reduce its dependence on Asian countries such as China, India, and Japan for antibiotics and other essential medications. This initiative is part of the newly proposed Critical Medicines Act, which aims to strengthen Europe’s pharmaceutical supply chain and ensure a stable sup...

GlaxoSmithKline Faces Regulatory Scrutiny Over Social Media Misstep

Nikhil Prasad Feb 22, 2025 2 months ago

Pharma News: A Simple Click That Sparked a Controversy GlaxoSmithKline (GSK), a major pharmaceutical company, has come under scrutiny by the Prescription Medicines Code of Practice Authority (PMCPA), the self-regulatory body overseeing pharmaceutical marketing in the United Kingdom. The controversy arose after a UK-based employee of GSK clicked "celebrate" on a LinkedIn post about a pre...

Bucillamine Shows Promise for Long COVID Treatment as Revive Therapeutics Expands Research

Nikhil Prasad Feb 04, 2025 2 months ago

Pharma News: Revive Therapeutics, a specialty life sciences company, has intensified its research and development efforts to explore the potential of Bucillamine for treating Long COVID and other medical conditions. Bucillamine, an oral drug with strong anti-inflammatory and antiviral properties, has been used for over 30 years in Japan and South Korea for rheumatoid arthritis. Recent studies sugg...

Ottimo Pharma Advances in the Race to Revolutionize Cancer Treatment

Nikhil Prasad Jan 02, 2025 4 months ago

Pharma News: David Epstein, a seasoned veteran in the pharmaceutical industry, had decided to retire after selling Seagen, a leading cancer drug company, to Pfizer for a staggering $43 billion. After an illustrious career that included pivotal roles at Novartis and Flagship Pioneering, Epstein planned to take a step back and guide budding biotechs from the sidelines. However, a compelling proposal...

Gilead That Gave the World the Toxic Useless COVID-19 Drug Remdesivir is Laying Off Staff

Nikhil Prasad Dec 10, 2024 4 months ago

Pharma News: Biotech giant Gilead Sciences, once hailed for its pharmaceutical advancements, is now in the spotlight for a different reason: significant layoffs and office closures. Known globally for its contributions to HIV treatment and its controversial COVID-19 drug, Remdesivir, the California-based company has announced plans to cut over 100 positions at its Foster City headquarters. Gilea...

Lily’s Tirzepatide Holds Promise for Diabetes Prevention

Nikhil Prasad Nov 14, 2024 5 months ago

Pharma News: Introduction to Tirzepatide and its Groundbreaking Study In an impressive three-year study, pharmaceutical giant Eli Lilly presented data that highlights tirzepatide's remarkable potential in preventing Type 2 diabetes among prediabetic individuals. This Indianapolis-based company has conducted extensive research on tirzepatide, a dual GIP/GLP-1 receptor agonist, which has shown ...

SIGA Technologies faces major legal issues as its Mpox drug Tpoxx (Tecovirimat) fails and its CMO is terminated

Nikhil Prasad Oct 08, 2024 6 months ago

Pharma News: SIGA Technologies, a pharmaceutical company known for its antiviral treatments, has recently encountered a significant setback that has shaken investor confidence and caused the company’s shares to plummet. The Mpox therapy, which the company had invested substantial resources and hopes in, failed to meet clinical expectations. In a dramatic development, SIGA has also announced ...

Pharma news - Regeneron secures European approval for innovative lymphoma drug Ordspono

Chitra Varughese Sep 02, 2024 8 months ago

Pharma News: Regeneron Pharmaceuticals has achieved a significant milestone with the European Commission's approval of its bispecific antibody drug, Ordspono (odronextamab), for the treatment of two types of lymphoma. This approval marks a crucial step for the company, especially after facing rejection from the U.S. Food and Drug Administration (FDA). The European Commission's decision now...

Sanofi’s children allergy medications recalled in India due to possible microbiological contamination

James Josh Aug 12, 2024 8 months ago

Pharma News: In a significant development affecting the Indian pharmaceutical market, French multinational pharma giant Sanofi has announced the voluntary recall of two popular children's medications - Allegra Suspension (Fexofenadine Hydrochloride Suspension) and Combiflam Suspension (Ibuprofen and Paracetamol Suspension). The recall has been initiated as a precautionary measure due to concer...

Asceneuron secures 100 million dollars for new Alzheimer drug

Nikhil Prasad Jul 23, 2024 9 months ago

Pharma News: A New Dawn for Alzheimer's Treatment In the relentless pursuit of breakthroughs in Alzheimer's disease treatment, Asceneuron, a Swiss biotechnology company, has made significant strides. The company recently announced the successful completion of a US$100 million Series C funding round, spearheaded by Novo Holdings. This financial boost is set to propel Asceneuron's innov...

New U.S. FDA Approval Expands Use of Amgen’s BLINCYTO for Leukemia

Nikhil Prasad Jun 17, 2024 10 months ago

Pharma News: The US Food and Drug Administration (FDA) has granted approval for Amgen’s BLINCYTO (blinatumomab) to treat CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (B-ALL) in patients aged over one month. This approval is significant for both adult and pediatric patients in the consolidation phase of their treatment. New U.S. FDA Appro...

Pharma News: U.S. FDA Approves Moderna's mRNA RSV Vaccine for Seniors, mRESVIA

Nikhil Prasad Jun 03, 2024 11 months ago

Pharma News: Despite all the controversies regarding the COVID-19 vaccines and the new mRNA technology, Moderna has received the U.S. FDA approval for its latest vaccine, mRESVIA, designed to protect older adults from respiratory syncytial virus (RSV). The pharma giant claims that this approval marks a critical milestone for the biotech company, showcasing its mRNA technology's versatility and...

Young Boy Dies During Clinical Trial Of Pfizer’s New Drug For Duchenne Muscular Dystrophy (DMD). Study Paused

Nikhil Prasad May 12, 2024 11 months ago

Pharma News: Duchenne muscular dystrophy (DMD) is a devastating genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects boys, typically diagnosed in early childhood, and leads to mobility challenges, respiratory complications, and a shortened lifespan. With limited treatment options available, DMD represents a significant unmet medical need, spurring in...

American Pharma Giant - Pfizer To Settle More Than 10,000 Lawsuits For Its Gastric Reflux Drug Zantac That Causes Cancer!

Nikhil Prasad May 10, 2024 12 months ago

Pharma News: In recent years, Pfizer, one of the world's largest pharmaceutical companies that is primarily of American origins, has found itself entangled in a legal battle concerning its popular heartburn drug, Zantac. The company has agreed to settle more than 10,000 lawsuits related to allegations that it concealed the cancer risks associated with Zantac. This development that is covered i...

U.S. FDA Accelerated Approval Of Sarepta Therapeutics’ Gene Drug Elevidys For Duchenne Muscular Dystrophy Being Questioned!

Nikhil Prasad May 06, 2024 12 months ago

Pharma News: In the realm of drug development and regulatory approval, the decision-making process is often complex, balancing the urgent need for effective treatments with the necessity of robust clinical evidence. One recent case that has sparked significant discussion and scrutiny is the U.S. Food and Drug Administration’s (FDA) accelerated approval of Elevidys, a gene therapy developed b...

Californian-Based ImmunityBio Team Ups With Serum Institute of India To End Merk’s Monopoly On BCG Vaccine Supply

Nikhil Prasad May 05, 2024 12 months ago

Pharma News: In the realm of medical breakthroughs and pharmaceutical advancements, the synergy between research entities and manufacturing powerhouses often heralds new eras of treatment accessibility and efficacy. The recent partnership between ImmunityBio and the Serum Institute of India stands as a prime example of such collaboration. This new alliance aims to tackle the longstanding monopoly ...

Sapropterin Dihydrochloride Made By Dr Reddy Laboratories For Lowering Blood Phenylalanine Being Recalled Across America Due To Potency Issues!

Nikhil Prasad Apr 24, 2024 1 year ago

Pharma News: In recent news, Dr. Reddy's Laboratories Ltd, a leading pharmaceutical company, has taken the proactive step of initiating a voluntary recall of six lots of Sapropterin Dihydrochloride powder for oral solution 100 mg in the US market. This recall, driven by concerns over potential potency issues, has significant implications for patients relying on this medication to manage hyperp...

Brigham Study Finds That More Than 50 Percent Of Cancer Drugs Granted Accelerated Approval By U.S. FDA Do Not Work And Sometime Kills!

Nikhil Prasad Apr 09, 2024 1 year ago

Pharma News: The U.S. Food and Drug Administration's (FDA) accelerated approval program has long been hailed as a crucial pathway for providing early access to potentially life-saving drugs, particularly in the realm of cancer treatment. Established in 1992 initially to address the urgent need for HIV/AIDS medications, this program allows for expedited approval of drugs that show promising ini...

Blackrock Funds Moderna US$750 Million Dollars To Develop mRNA Flu Vaccines, Validating That A Flu Virus Is Likely One Of The Three Disease X Pathogens!

Nikhil Prasad Mar 28, 2024 1 year ago

Pharma News: In a significant development within the pharmaceutical industry, Moderna, a pioneering biotechnology company known for its controversial COVID-19 mRNA-based vaccines, has secured a substantial financial boost from Blackstone Life Sciences. The investment, amounting to US$750 million, is aimed at advancing Moderna's influenza (flu) vaccine program, marking a strategic collaboration...

Med News: Pfizer’s Pregabalin That Is Used To Treat Anxiety And Neuropathic Pain Linked To Rising Drug Related Deaths!

Nikhil Prasad Mar 13, 2024 1 year ago

Med News: In recent years, the commonly prescribed anxiety drug pregabalin has come under scrutiny due to a significant increase in linked fatalities. This surge in deaths, which more than doubled from 187 in 2018 to 441 in 2022 in England and Wales, has sparked concerns about the safety of this medication. Death registrations related to Gabapentin or Pregabalin, England and Wales: 2018 and 2022 ...

Pharma News: Pfizer Halts Seagen Plant Project! Speculations That Pfizer Might Face A Potential Wave Of Law Suits Over The COVID-19 Jabs!

James Rosh Mar 08, 2024 1 year ago

Pharma News: In a surprising turn of events, pharmaceutical giant Pfizer recently announced the abrupt halt of the US$350 million Seagen plant construction project, a mere three months after completing the $43 billion acquisition of Seagen in December. This unforeseen decision has left 120 workers' roles hanging in the balance, while industry analysts speculate that Pfizer may face a potential...

Pharma News: 374 Medicine Samples Fail Quality Tests In Himachal Pradesh-India

Nikhil Prasad Feb 28, 2024 1 year ago

Pharma News: In a disconcerting turn of events, the pharmaceutical industry in Himachal Pradesh, India, is facing intense scrutiny as 374 medicine samples from companies located in the Baddi-Barotiwala and Nalagarh areas have failed quality tests in the past year. The revelation came to light during the Question Hour session in the Assembly House, raising concerns among various Members of the Legi...

Pharma News: Daiichi Sankyo Faces Regulatory Scrutiny And Reprimand For Marketing Communication Violations

Nikhil Prasad Feb 27, 2024 1 year ago

Pharma News: Daiichi Sankyo, a prominent pharmaceutical company, finds itself entangled in a web of regulatory violations and reprimands from the U.K.'s Prescription Medicines Code of Practice Authority (PMCPA). The allegations revolve around the marketing communications pertaining to Daiichi's cholesterol-lowering drugs, Nilemdo and Nustendi. Despite vehemently denying any wrongdoing, the...

Pharma News: European Medicines Agency Approves And Recommends A Slate Of Promising Drugs Including Filspari, Carvykti, Tizveni And Reblozyl

Nikhil Prasad Feb 26, 2024 1 year ago

Pharma News: In recent pharmaceutical news, the European Medicines Agency (EMA) has issued a series of approvals and positive recommendations for several groundbreaking drugs, showcasing the relentless efforts of the pharmaceutical industry in advancing treatments for various medical conditions. Among the notable approvals are Travere Therapeutics' Filspari for IgA nephropathy, Johnson & J...

Pharma News: Gilead Facing Multiple Lawsuits Over Its Tenofovir Disoproxil Fumarate-Based HIV Drugs

Nikhil Prasad Jan 17, 2024 1 year ago

Pharma News: In the ever-evolving landscape of pharmaceutical litigation, Gilead Sciences has found itself embroiled in a protracted legal battle over its Tenofovir Disoproxil Fumarate (TDF)-based HIV drugs. The core of the dispute revolves around allegations of negligence, an unconventional approach where the focus is not on the inherent defects of the drug but on the purported delay in developin...

Pharma News: Pfizer Acquires Cancer Drug Company Seagen For 43 Billion US Dollars In Anticipation Of The Rise In Turbo Cancers!

Nikhil Prasad Jan 04, 2024 1 year ago

Pharma News: In an unexpected and controversial move, pharmaceutical behemoth Pfizer has plunged into the realm of oncology with the acquisition of Seagen, a small drug company specializing in the treatment of "turbo cancers." https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-seagen This staggering US$43 billion deal has left many p...

Pharma News: Novo Nordisk's Strategic Expansion In Ireland - A Paradigm Shift in Global Biopharmaceutical Manufacturing

Nikhil Prasad Jan 02, 2024 1 year ago

Pharma News: In a groundbreaking move that signals a paradigm shift in the global biopharmaceutical manufacturing landscape, Novo Nordisk, the eminent player in GLP-1 diabetes and weight-loss drugs, is aggressively expanding its footprint in Ireland. The recent acquisition of an Alkermes pill factory in Athlone and the submission of a planning application for an expansive manufacturin...

BREAKING Pharma News! European Medicines Agency Suspends More Than 400 Generic Drugs From India Over Flawed And Possible Fraudulent Studies In Pune!

Nikhil Prasad Dec 31, 2023 1 year ago

Pharma News: India is a country where doctors and researchers can be easily bought for small sums of monies to manipulate studies and officials at regulatory agencies in India can be easily bribed to issue relevant drug and supplement approvals or licenses despite ‘half-baked’ supporting data. Worse, the various companies in India that are known to manufacture various generic drugs, su...

Pharma News: LimmaTech Biologics Secures Exclusive Clinical Development Rights From AbVacc For Vaccine Against Staphylococcus Aureus

Nikhil Prasad Dec 19, 2023 1 year ago

Pharma News: In a groundbreaking move to address the escalating global threat of antimicrobial resistance (AMR), LimmaTech Biologics has secured exclusive clinical development rights from AbVacc for the revolutionary multivalent toxoid vaccine candidate, LBT-SA7 (formerly IBT-V02), designed to combat infections caused by the notorious bacterial pathogen, Staphylococcus aureus (S. aureus). This str...

Pharma News: Sanofi Announces Groundbreaking Agreement for Potential First-in-Class Vaccine Against Extraintestinal Pathogenic E. Coli

Nikhil Prasad Oct 03, 2023 2 years ago

Pharma News: In a significant step forward for public health, Sanofi has announced a groundbreaking agreement with Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, to develop and commercialize a potential first-in-class vaccine targeting extraintestinal pathogenic Escherichia coli (ExPEC). This innovative vaccine, currently in Phase 3 clinical trials, aims to combat ExPEC's deva...

Pharma News: U.S. FDA Approves Bristol Myers Squibb's Reblozyl As First-Line Treatment For Anemia In Adults With Lower-Risk Myelodysplastic Syndromes

Thailand Medical News Team Aug 29, 2023 2 years ago

Pharma News: In a significant breakthrough for the treatment of lower-risk myelodysplastic syndromes (MDS), the U.S. Food and Drug Administration (FDA) has granted approval for Reblozyl® (luspatercept-aamt), developed by Bristol Myers Squibb. This approval marks a turning point in addressing chronic anemia in adult patients with very low- to intermediate-risk MDS who may require regular red bl...

Pharma News: Swedish Researchers Warn That Many Cancer Drugs Are Being Approved Despite Lack Of Proper Efficacy!

Thailand Medical News Team Aug 18, 2023 2 years ago

Pharma News: The rapid pace of innovation in the pharmaceutical industry has led to the frequent launch of new cancer drugs, promising hope for patients battling this formidable disease. However, a concerning trend has emerged, revealing that many of these drugs receive approval before substantial evidence of their long-term effectiveness can be established. In an era where resources are finite an...

Pharma News: Lawsuit Alleges Ozempic and Mounjaro Diabetes/Weigh Loss Drugs Cause Severe Stomach Problems Including Gastroparesis Or Stomach Paralysis!

Thailand Medical News Team Aug 17, 2023 2 years ago

Pharma News: A lawsuit has been filed against pharmaceutical giants Novo Nordisk and Eli Lilly, makers of the widely used type 2 diabetes drugs Ozempic and Mounjaro. The lawsuit claims that these medications, which are also prescribed off-label for weight loss, have caused severe stomach problems in patients, including a condition known as gastroparesis, or stomach paralysis. The Laws...

Much Sought After Overpriced Obesity Drug Wegovy By Novo Nordisk Found To Lower Adverse Cardiovascular Events By 20 Percent!

Thailand Medical News Team Aug 09, 2023 2 years ago

Pharma News: In a groundbreaking development, Novo Nordisk's revolutionary weight loss drug, Wegovy, has not only captured the attention of the weight-conscious population but has now demonstrated a remarkable potential to significantly lower the risk of major cardiovascular events (MACE). The results of an extensive clinical trial have unveiled a 20% reduction in the occurrence o...

University of Georgia Scientists Discover New Active Pharmaceutical Ingredient (API) - A Molecule Called POM-L-BHDU To Treat Varicella Zoster Virus

Thailand Medical News Team Aug 09, 2023 2 years ago

Pharma News: You've probably seen the unsettling commercial that warns that the virus responsible for shingles might already be lurking within you if you had chickenpox as a child. This chilling message serves as a reminder for people to consider getting the shingles vaccine. But, alas, the vaccine doesn't provide foolproof protection against shingles; it simply helps mitigate the symptoms...

Pharma News: Pulmonary Arterial Hypertension (PAH) Treatments Driving Growth For Many Pharmaceutical Companies

Thailand Medical News Team Aug 07, 2023 2 years ago

Pharma News: According to data from the pharma industry, the global market for pulmonary arterial hypertension (PAH) treatments is on track to reach nearly US$11 billion by 2030, making PAH drugs highly sought-after assets in the biopharmaceutical industry. While the projected figures for other markets, such as non-alcoholic steatohepatitis and obesity, may be more substantial, the unique appeal o...

BREAKING NEWS! Pharma News: A Common Painkiller's Hidden Danger Uncovered - Millions at Risk From Using Diclofenac!

Pharma News - diclofenac - UGT2B17 May 01, 2023 2 years ago

Pharma News: New research has unveiled the potential reason behind the alarming side effects of a widely-used painkiller, diclofenac, putting millions of people at risk for severe complications. A misunderstood enzyme responsible for metabolizing the drug may be the key factor leading to serious health consequences, including heart damage. In a groundbreaking study, scientists have discovered a s...

MUST READ! COVID-19 News: SARS-CoV-2 Altered Blood-Brain Barrier Opens Questions About Drugs Used During Treatments And Their Effects!

COVID-19 News - SARS-CoV-2 Altered Blood-Brain Barrier - Drug Transport Apr 01, 2023 2 years ago

COVID-19 News: A new study by Mexican medical scientists has found that SARS-CoV-2 virus is able to alter the Blood-Brain Barrier of the human host with concerning implications as many of the drugs used during treatment can also thereafter gain access to the brain when in the first place, during development and research, they were made knowing very well that their active molecules would never be a...

Pharma News: Shortage Of Nitroglycerin Spray, A Heart Medication In Canada Is Expected to Extend To The America and Europe Due To Raw Materials Crisis

Pharma News -Nitroglycerin Spray Shortage Mar 22, 2023 2 years ago

Pharma News: Shortage Of Nitroglycerin Spray, A Heart Medication In Canada Is Expected to Extend To The America and Europe Due To Raw Materials Crisis. Pharma News: A shortage of a critical heart medication, nitroglycerin spray, has sparked concerns among patients and healthcare providers in Canada, particularly in Alberta. The fast-acting nitroglycerin spray is used by spraying on...

U.S. Medical News: Pfizer Withdraws Millions of Nurtec ODT Migraine Tablet Packs In The United States

U.S. Medical News - Pfizer Recalls Nurtec ODT Migraine Tablets Mar 19, 2023 2 years ago

U.S. Medical News: Pfizer has initiated the withdrawal of millions of Nurtec ODT Migraine tablet packs in the United States due to the lack of necessary child-resistant blister packs, which, according to U.S. regulators, present a poisoning hazard to children. In all, more than four million blister packs of Pfizer’s prescription migraine drug Nurtec ODT is being recalled in Amer...

Medical Warnings: BEWARE! Many Online “Patient Influencers” Are being Paid By Pharmaceutical Companies To Mislead Viewers On Prescription Drugs!

Medical Warnings - Online Influencers Mar 14, 2023 2 years ago

Medical Warnings: A new study led by researchers from University of Colorado-USA has found that many online “Patient Influencers” are being paid by pharmaceutical companies to mislead viewers on prescription drugs! In some cases, these online medical influencers are not just previous patients but also doctors, researchers and so called “experts’ and even advocacy o...

Pharma News: Thailand Medical News Calls For Urgent Research Of Incorporating Silver Nanoparticles To Existing Antivirals To Treat COVID-19 And H5N1!

Pharma News -Silver Nanoparticles - Antivirals - COVID-19 - H5N1 Mar 13, 2023 2 years ago

Pharma News: The ongoing COVID-19 pandemic with the emergence of new variants and sub-lineages have made identifying effective treatments become even more challenging. Unknown to many, drug resistance has developed in many of these new sub-lineages not only with the used of officially approved antivirals such as remdesivir, paxlovid, molnupiravir, favipiravir but even with drugs unofficially an...

Pharma News: Apotex Recalls Glaucoma And Ocular Hypertension Drug Brimonidine Tartrate Ophthalmic Solution Due To Sterility Concerns

Pharma News - Apotex Mar 09, 2023 2 years ago

Pharma News: Apotex, Canada's largest generic drug maker, has announced a recall of six batches of the glaucoma and ocular hypertension drug brimonidine tartrate ophthalmic solution due to sterility concerns. https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/apotex-corp-issues-voluntary-nationwide-recall-brimonidine-tartrate-ophthalmic-solution-015-due The company is...

Pharma News: Danish Authorities Initiates Recall Of Sandoz’s Dicillin Antibiotic After Outbreak of Carbapenemase-Producing ST79 Enterobacter Hormaechei!

Pharma News - Sandoz Dicillin Feb 24, 2023 2 years ago

Pharma News: The Danish Medicines Agency has initiated a recall of Sandoz’s Dicillin antibiotics after it was discovered that the drugs were contaminated and lead to users developing an infection involving Carbapenemase-Producing ST79 Enterobacter Hormaechei. https://laegemiddelstyrelsen.dk/da/nyheder/2023/antibiotikalaegemidlet-dicillin-fra-firmaet-sandoz-tilbagekaldes/ The recall ...

Pharma News: University Of California Researchers Warns That NSAIDs Like Ibuprofen And Naproxen Actually Worsens Arthritis Inflammation!

Pharma News - Ibuprofen - Naproxen Nov 25, 2022 2 years ago

Pharma News: A new study lead by researchers from the Department of Radiology and Biomedical Imaging at the University of California, San Francisco- USA have found that the usage of pain relievers like Ibuprofen and Naproxen actually worsens arthritis inflammation. The study team warns that the use of NSAIDS such as ibuprofen and naproxen might not have the desired effect patients are see...

Pharma News: Nirmatrelvir (A Key Component Of Paxlovid) Blunts Development Of Antiviral Adaptive Immune Responses In SARS-CoV-2 Infected Mice!

Pharma News - Paxlovid Nov 23, 2022 2 years ago

Pharma News: A new study by Italian researchers has shockingly found that Nirmatrelvir which is a key component of the drug Paxlovid that is being peddled by American and British medical ‘experts’ to treat COVID-19 actually blunts the development of antiviral adaptive immune responses in mice infected with SARS-CoV-2! According to the study team, this might help explain the vi...

First Novel Antibiotic Since 20 Years, Gepotidacin Debuts To Treat Drug Resistance Urinary Tract Infections (UTIs) Amidst Growing Incidences!

Source: Pharma News - Gepotidacin - UTIs Nov 05, 2022 2 years ago

Pharma News: Pharma giant, GSK has developed a new antibiotic called Gepotidacin that could fight tough-to-treat drug resistance urinary tract infections (UTIs). Phase 3 clinical trials proved to not only be successful but demonstrated the efficacy of the drug beyond the researchers’ expectations that the trials ended earlier than expected. https://www.gsk.com/en-gb/media/press-rele...

Pharma News: Azurrx Biopharma’s Proprietary Niclosamide Formulations To Treat COVID-19 Gastrointestinal Infections

Source: Pharma News Jan 05, 2021 4 years ago

Pharma News: Florida based AzurRx BioPharma, a company specializing in the development of non-systemic therapies for gastrointestinal (GI) diseases has announced that it has signed an exclusive worldwide licensing agreement with First Wave Bio, Inc for the use of their patented and proprietary oral and rectal formulations of niclosamide for the treatment of immune checkpoint inhibitor-as...

Pharma News: Roche Partners With Regeneron On The New Antiviral Antibody Combination, REGN-COV2 As A Potential Treatment OF COVID-19

Source: Pharma News Sep 25, 2020 5 years ago

Pharma News: Pharma giant Roche has partnered with Regeneron Pharmaceuticals to develop, manufacture and distribute Regeneron’s antiviral antibody combination, REGN-COV2, as a potential treatment of COVID-19. The new antibody combination REGN-COV2 could help treat patients with symptoms and also prevent the disease in individuals exposed to the SARS-CoV-2 coronavirus. An init...

Pharma News: Swiss Pharma Giant Novartis Launches PR Initiative To Supply COVID-19 Meds To Low And Middle-Income Countries

Source: Pharma News Jul 20, 2020 5 years ago

Pharma News: One of the world’s biggest pharma giant Novartis, in a PR move publicly announced the launch an initiative to assist patients in low-income and lower-middle-income countries in getting access to affordable drugs for COVID-19. The pharma company said that they are specifically making 15 drugs from its Sandoz division available that can be used to treat symptoms...

Pharma Company That launched First US FDA Approved Cannabis Based Epilepsy Drug Post US$ 296 Million in Sales Turnover For First Year.

Source: Thailand Medical News Jan 18, 2020 5 years ago

Sales figures for the first cannabis-based medicine in the United States are in and they’re telling a bullish story, according to GW Pharmaceuticals CEO Justin Gover. The drug, Epidiolex, which contains cannabidiol to treat severe forms of epilepsy, brought in $104 million in net sales in the fourth quarter and a total of $296 million in 2019 across the globe, the British pharma...

Pharmaceutical News Industry Abuzzed About Bryn Pharma Securing US$17.5 Million Funding For New Epinephrine Nasal Spray To Treat Anaphylaxis

Source: Thailand Medical News Jan 17, 2020 5 years ago

The pharmaceutical news and media segment is abuzzed about a new development that will disrupt the way that individuals with allergies or reactions having anaphylaxis episodes are treated or able to treat themselves. A privately held Raleigh medical device company called Bryn Pharma, is on track to soon provide people who have severe, possibly life-threatening allergies a needle-free option t...

Galen Pharma Buys Swedish POA Pharma In A Multi-Million Pound Deal

Source: Thailand Medical News Jan 08, 2020 5 years ago

Galen Pharma, a Northern Ireland-based, globally focused pharmaceutical sales and marketing firm has acquired Swedish-headquartered POA Pharma in a multi-million pound takeover agreement. This takeover allows Galen to expand its global footprint further into Scandinavia and Northern Europe. POA Pharma has offices and facilities in Denmark, Sweden, Norway and Finland. The buy out will also broad...

Merck Collaborates With Taiho And Astex For Oncology Research On Developing Small Molecule Inhibitors

Source: Thailand Medical News Jan 06, 2020 5 years ago

Pharma giant, Merck also known as MSD outside the United States and Canada, has announced an exclusive worldwide research collaboration and license agreement with Taiho Pharmaceutical Co, Ltd., (“Taiho”) and Astex Pharmaceuticals (UK), a wholly owned subsidiary of Otsuka Pharmaceutical Co., Ltd. (“Astex”), focused on the development of small molecule inhibitors agains...

Interesting Reads

Study Reveals That COVID-19 Alters Key Human Genes

Nikhil Prasad
Nov 05, 2024 6 months ago

SARS-CoV-2 XEC Variant Shows Enhanced Immune Evasion through NTD Glycosylation

Nikhil Prasad
Oct 24, 2024 6 months ago

Many exposed to COVID-19 will develop Acute Ischemic Colitis!

Nikhil Prasad
Oct 21, 2024 6 months ago

Study reveals the SARS-CoV-2 spike protein interacts with over 60,000 host proteins and may trigger carcinogenesis!

Nikhil Prasad
Oct 07, 2024 7 months ago

Breaking News! Study Reveals Potential New Form of Brain Neurodegeneration Linked to COVID-19!

Nikhil Prasad
Oct 02, 2024 7 months ago

Word-Finding Challenges Linked to Post-COVID-19 Syndrome

Nikhil Prasad
Oct 02, 2024 7 months ago

Italian study discovers new subtype of T-cells as immune players in COVID-19

Nikhil Prasad
Sep 29, 2024 7 months ago

Texas scientist warns of new SARS-CoV-2 neuroinvasion pathway involving the trigeminal nerve

Nikhil Prasad
Sep 26, 2024 7 months ago

COVID-19 induced endothelial dysfunction will lead to a pandemic of chronic kidney and cardiovascular diseases

Nikhil Prasad
Aug 08, 2024 8 months ago

Researchers warn that SARS-CoV-2 can infect the Meibomian glands of the eyes

Nikhil Prasad
Jul 26, 2024 9 months ago

Murine study shows how COVID-19 increases risk for stroke

Nikhil Prasad
Jul 25, 2024 9 months ago

COVID-19 can cause Osteomyelitis of the jaw

Nikhil Prasad
Jul 24, 2024 9 months ago

SARS-CoV-2 spike protein accelerates aging of blood vessels

Nikhil Prasad
Jul 23, 2024 9 months ago

COVID-19 causes Blood DNA Methylation, a potential biomarker for Long COVID severity

Nikhil Prasad
Jul 22, 2024 9 months ago

Doctors from Turkey warns that children exposed to SARS-CoV-2 are at risk of acute kidney injury

Nikhil Prasad
Jul 22, 2024 9 months ago

Forget about the KP.3, LB.1, KP.2.3 variants. The new SARS-CoV-2 KP.3.1.1 is leading the current global COVID-19 surge

Nikhil Prasad
Jul 21, 2024 9 months ago

Unknown To Many Including Doctors, COVID-19 Causes Parsonage Turner Syndrome

Nikhil Prasad
Jul 08, 2024 10 months ago

SARS-CoV-2 Causes ACE2 Downregulation and Unique Fibrosis That Contribute to Long COVID-19

Nikhil Prasad
Jun 28, 2024 10 months ago

COVID-19's Hidden Impact on Eyes: Unveiling Rare Retinal Conditions

Nikhil Prasad
Jun 24, 2024 10 months ago

Somnolence And Shingles Seems To Be New Symptom/Manifestation Of COVID-19 KP.3 And LB.1 Infections!

Nikhil Prasad
Jun 23, 2024 10 months ago

COVID-19 and Stroke: New Insights on Inflammation and Recovery

Nikhil Prasad
Jun 22, 2024 10 months ago

Herbs And Phytochemicals: Fermented Codonopsis lanceolata Root Extract Shows Promise Against Influenza A Virus

Nikhil Prasad
Jun 22, 2024 10 months ago

Herbs And Phytochemicals: Oleuropein From Olive Leaf Can Help Against Colorectal Cancer

Nikhil Prasad
Jun 15, 2024 10 months ago

Mild Or Moderate COVID-19 Causes Accelerated Brain Aging Especially In Young To Early Middle-Aged Adults!

Nikhil Prasad
Mar 12, 2024 1 year ago

Six Percent Of All Post-COVID Patients Who Have Hip Discomfort Likely To Have Developed Avascular Necrosis Of The Femoral Head!

Nikhil Prasad
Mar 10, 2024 1 year ago

New Measles Variant That Can Evade Current Diagnostics Identified In Italy! More New Strains To Be Announced Soon!

Nikhil Prasad
Feb 20, 2024 1 year ago

BREAKING COVID-19 News! Study Claims That Omicron Infections Can Lead To Acute Primary Angle Closure And Also Primary Angle Closure Glaucoma!

Nikhil Prasad
Jan 02, 2024 1 year ago

BREAKING COVID-19 News! Australian Scientists Discover A microRNA Called CoV2-miR-O8 That Is Encoded By SARS-CoV-2 And Is Possibly Pathogenetic!

Nikhil Prasad
Dec 16, 2023 1 year ago

COVID-19 News: Foods Rich In XeSiAs-Neu5Gc Contributes To Xenosialylation That Causes Worse Outcomes In SARS-CoV-2 Infections And Vaccination!

Nikhil Prasad
Dec 15, 2023 1 year ago

COVID-19 News: Researchers Warn That SARS-CoV-2 Infections Can Lead To Splenic Infarctions!

Nikhil Prasad
Dec 14, 2023 1 year ago

COVID-19 News: SARS-CoV-2 Is Likely An Oncogenic Virus That Will Cause Lung, Colorectal, Oral, Pancreatic And Breast Cancers In The Long Term!

Nikhil Prasad
Oct 23, 2023 2 years ago

BREAKING COVID-19 News! SARS-CoV-2 Affects Red Blood Cell Morphology!

Nikhil Prasad
Oct 04, 2023 2 years ago

BREAKING! Scientists Warns That SARS-CoV-2 Also Interacts With IGF2BP1- An Oncofetal RNA-Binding Protein That Typically Fuels Tumor Virus Propagation!

Medical News - SARS-CoV-2 - IGF2BP1
Jun 29, 2023 2 years ago

BREAKING NEWS! Even Asymptomatic SARS-CoV-2 Infections Cause DNA Methylation And Epigenetic Changes, Leading to Immune Dysregulation!

COVID-19 News - DNA Methylation - Asymptomatic SARS-CoV-2 Infections
Jun 10, 2023 2 years ago

Study Shockingly Shows That Many Exposed To The SARS-CoV-2 Omicron Variant Exhibit Hematuria And Proteinuria! Early Signs Of Possible Kidney Damage?

COVID-19-News-Omicron-Hematuria-Proteinuria-Kidney-Damage
May 30, 2023 2 years ago

Phenolic Phytochemicals From The Roselle Plant Or Hibiscus Sabdariffa (Thai: Krachiap กระเจี๊ยบ) Can Treat And Prevent Obesity

Herbs And Phytochemicals - Roselle - Obesity
Mar 08, 2023 2 years ago

BREAKING! COVID-19 News: SARS-CoV-2 Infections Lead To Increased Risk Of Breast Cancer, Recurrence Of Breast Cancer And Also Breast Cancer Metastasis!

COVID-19 News - Breast Cancer
Feb 07, 2023 2 years ago

BREAKING! Study Finds That Cancer Causing Genes Are Upregulated In SARS-CoV-2 Infected Individuals!

Source: Medical News - SARS-CoV-2 & Cancer
Aug 04, 2022 3 years ago

BREAKING! Hypothesis That Majority Exposed To SARS-CoV-2 Will Have Shortened Lifespans Validated By Study Showing NSP2 Impairs Human 4EHP-GIGYF2 Complex!

Source: Medical News -SARS-CoV-2 Reduces Human Life Spans
Jun 27, 2022 3 years ago

FROM HMPV HUMAN METAPNEUMOVIRUS

LATEST ON HANTAVIRUS NEWS

World COVID-19 News

COVID-19 Diagnostics

COVID-19 Drugs

COVID-19 Supplements

COVID-19 Herbs

COVID-19 Disinfectants

COVID-19 Mutations

COVID-19 Research

COVID News

Long COVID

COVID-19 Vaccines

COVID-19 Clinical Care

Medical Press Releases

Medical Innovations & Startups

AI in Medicine

Thailand Biotech News

Medical Spheres Bulletins

Medical White Papers

Medical Packages

Medical Tips

Medical Support Groups

MOST READ

Interesting Reads

FROM HMPV HUMAN METAPNEUMOVIRUS

LATEST ON HANTAVIRUS NEWS